Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised phase II trial of definitive radiotherapy with or without metformin in inoperable stage III NSCLC
2017-004877-15Phase 2Completed
- Sponsor
- Antwerp University Hospital
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of metformin in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Antwerp University Hospital. Primary endpoint: Locoregional progression-free survival at 1 year (LPFS). Started Mar 2018; status: completed.
02
Drugs
metformin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2017-004877-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004877-15.